Nan Zhang
机构:The Wistar Institute, Qingdao University, Ministry of Education of the People's Republic of China, Liaoning Normal University, Shandong University, Harbin Medical University, Chongqing University, Shanxi Medical University, Xuzhou Medical College, Capital Medical University, Dalian Medical University, Jilin University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Sichuan University, Peking Union Medical College Hospital, Chinese PLA General Hospital, AbbVie (United States), Tianjin Synthetic Material Research Institute (China), West China Hospital of Sichuan University, Henan Academy of Sciences, Peking University Cancer Hospital, Second Affiliated Hospital of Chongqing Medical University, Shaanxi Xueqian Normal University, Chinese Institute for Brain Research, Affiliated Hospital of Qingdao University, Beijing Anzhen Hospital, First Affiliated Hospital of Xi'an Jiaotong University, Fuzhou Pulmonary Hospital of Fujian, Mayo Clinic in Arizona, First Hospital of Jilin University, First Hospital of Shanxi Medical University, Beijing Aerospace General Hospital, Second Affiliated Hospital of Harbin Medical University, Second Hospital of Tianjin Medical University, Key Laboratory of Nuclear Radiation and Nuclear Energy Technology, Cellular Therapeutics (United Kingdom), Ministry of Education, Sanya University, Ministry of Agriculture and Rural Affairs, Shenzhen Technology University, Chongqing Cancer Hospital, Baotou Medical College, Shandong First Medical University, First Hospital of Xi'an, State Key Laboratory of Crystal Materials, Ping An (China), Chinese Academy of Fishery Sciences, Huazhong University of Science and Technology, Tianjin Medical University, Yangzhou University, Nanjing Medical University, Chongqing Medical University · ORCID:0000-0001-6518-2501
发表论文 390 篇 · 总被引 11289 次 · h-index 49
代表论文
- Integrated bioinformatics and multi-omics reveal Astragalus extract’s gut-kidney axis mechanism in hyperuricemic nephropathy via purine metabolism (2025 · Phytomedicine · 被引 15)
- Macrophage CCL7 promotes resistance to immunotherapy for colorectal cancer by regulating the infiltration of macrophages and CD8 + T cells (2025 · Journal for ImmunoTherapy of Cancer · 被引 10)
- Cholesterol 25‐Hydroxylase Enhances Myeloid‐Derived Suppressor Cell (MDSC) Immunosuppression via the Stimulator of Interferon Genes (STING)‐Tank‐Binding Kinase 1 (TBK1)‐Receptor‐Interacting Protein Kinase 3 (RIPK3) Pathway in Colorectal Cancer (2025 · MedComm · 被引 6)
- ECM-based molecular subtypes define prognostic, EMT status, and therapeutic diversity in IDH-mutant gliomas (2025 · npj Precision Oncology · 被引 6)
- First-line treatment with chemotherapy, surufatinib (an angio-immuno kinase inhibitor), and camrelizumab (an anti-PD-1 antibody) for locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II randomized study (2025 · Signal Transduction and Targeted Therapy · 被引 4)
- Ferroptosis and gastric cancer: from molecular mechanisms to clinical implications (2025 · Frontiers in Immunology · 被引 4)